Esabelle Lo Yan Yam

Esabelle Lo Yan Yam

Auto-generated profile, based on publicly available information

Esabelle Lo Yan Yam

Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2019 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
EYEsabelle Lo Yan Yam
Esabelle Lo Yan Yam
LHLi Yang HSU
Li Yang HSU
EYEric Peng Huat Yap
Eric Peng Huat Yap
TYTsin Wen Yeo
Tsin Wen Yeo
VLVernon Lee
Vernon Lee
AWAnnelies Wilder-Smith
Annelies Wilder-Smith
The Asia Pacific region, home to two-thirds of the world’s population and ten of the least developed countries, is considered a regional hot-spot for the emergence and spread of antimicrobial resistance (AMR). Despite this, there is a dearth of high-quality regional data on the extent of AMR. Recognising the urgency to close this gap, Singapore organised a meeting to discuss the problems in the region and frame a call for action. Representatives from across the region and beyond attended the meeting on the “Antimicrobial Resistance in the Asia Pacific & its impact on Singapore” held in November 2018. This meeting report is a summary of the discussions on the challenges and progress in surveillance, drivers and levers of AMR emergence, and the promising innovations and technologies that could be used to combat the increasing threat of AMR in the region. Enhanced surveillance and research to provide improved evidence-based strategies and policies are needed. The major themes that emerged for an action plan are working towards a tailored solution for the region by harnessing the One Health approach, enhancing inter-country collaborations, and collaboratively leverage upon new emerging technologies. A regionally coordinated effort that is target-driven, sustainable and builds on a framework facilitating communication and governance will strengthen the fight against AMR in the Asia Pacific region.

25 November 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Siyan YiSiyan Yi
Siyan Yi
EYEsabelle Lo Yan Yam
Esabelle Lo Yan Yam
KCKochukoshy Cheruvettolil
Kochukoshy Cheruvettolil
ELEleni Linos
Eleni Linos
AGAnshika Gupta
Anshika Gupta
KEKaren Eggleston
Karen Eggleston
Digital health innovations have emerged globally as a transformative force for addressing health system challenges, particularly in resource-constrained settings. The COVID-19 pandemic underscored the critical importance of these innovations for enhancing public health. In South and Southeast Asia, a region known for its cultural diversity and complex health care landscape, digital health innovations present a dynamic interplay of challenges and opportunities. We advocate for ongoing research built into system development and an evidence-based strategy focusing on designing and scaling national digital health infrastructures combined with a vibrant ecosystem or “marketplace” of local experiments generating shared experience about what works in which settings. As the global digital health revolution unfolds, the perspectives drawn from South and Southeast Asia—including the importance of local partnerships—may provide valuable insights for shaping future strategies and informing similar initiatives in low- and middle-income countries, contributing to effective digital health strategies across diverse global health contexts.

13 June 2020 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
EYEsabelle Lo Yan Yam
Esabelle Lo Yan Yam
On 1 June 2020, the World Health Organization (WHO) Director-General, Tedros Adhanom Ghebreyesus, called the threat of antimicrobial resistance (AMR) ‘one of the most urgent challenges of our time’, further exacerbated by the COVID-19 pandemic. 1 A review showed that 72% of 2010 patients diagnosed with COVID-19 received antibacterial therapy, even though only 8% of cases were reported with bacterial or fungal co-infection in studies reporting bacterial co-infection in COVID-19 cases. 2 Similar to other viral diseases such as dengue, COVID-19 patients present with undifferentiated fever and respiratory conditions that may be empirically treated as bacterial upper respiratory infections. 3 Inappropriate use of antibiotics may be worsened or even considered reasonable when patients’ conditions deteriorate around day 8–12 of the illness. 2 Furthermore, COVID-19 patients who are critically ill often require prolonged hospitalization associated with nosocomial bacterial infections where antibiotics are needed.

28 June 2024 in Journal of Global Health
Verified
Journal Article
Open access
XXXinfang Xu
Xinfang Xu
DLDi Liang
Di Liang
JZJin kou Zhao
Jin kou Zhao
RMRose Mpembeni
Rose Mpembeni
JOJoyce Olenja
Joyce Olenja
JHJiayan Huang
Jiayan Huang
With 608 000 deaths annually in 2022, malaria remains a major public health challenge in sub-Saharan Africa over the past decade, despite worldwide efforts to eliminate it [1]. The burden of malaria has intensified, particularly in the aftermath of the COVID-19 pandemic and the expansion of mosquito habitats due to climate changes [2,3]. Malaria is mostly […]

2 December 2020 in Journal of Travel Medicine
Verified
Journal Article
Closed access
EYEsabelle Lo Yan Yam
Esabelle Lo Yan Yam
The origin of the severe acute respiratory syndrome coronavirus 2, the coronavirus that is still ravaging across the world almost a year after the first reported case, has been told in various ways—from the wildlife trade at the Wuhan wet market to the covert operations in laboratories. How does climate change fit in the narratives?

14 February 2025 in Journal of Global Health
Verified
Journal Article
Open access
YLYuhua Lai
Yuhua Lai
DLDi Liang
Di Liang
ABAlbino Bobogare
Albino Bobogare
BYBuyanjargal Yadamsuren
Buyanjargal Yadamsuren
EYEsabelle Yam
Esabelle Yam
JHJiayan Huang
Jiayan Huang
Universal health coverage (UHC) and global health security (GHS) are two critical global health agendas that share a common goal of improving population health [1,2]. UHC means providing access to comprehensive, appropriate, timely, and quality health services without financial hardship [3]. Meanwhile, GHS focuses on the proactive and reactive activities required to minimise the impact […]